Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
about
Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Circulating biomarkers that predict incident dementia.Circulating miRNA biomarkers for Alzheimer's diseaseDetection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteinsGenetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal FluidMass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.A curated review of recent literature of biomarkers used for assessing air pollution exposures and effects in humans.Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?FTIR and Raman Spectroscopy Applied to Dementia Diagnosis Through Analysis of Biological Fluids.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.Lipidomic Profiles in Diabetes and Dementia.Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
P2860
Q30651551-550A8D20-41AA-4340-AB16-3689CCC10E6CQ33752058-BE624E3E-B30F-49D5-A288-5813A829F9A7Q34904013-16846CC1-2824-4D3E-85D9-84747E73AEE1Q36934163-A5769E60-CF54-4A2B-AF05-57F73F7AC75FQ37044150-3688D957-EF92-4874-BBEE-21E613BB6762Q37054037-82DDC240-98E7-41F9-9A9D-53A577D11F22Q37342809-CAEF491F-1DCE-46EF-89DF-4D3E0D4EDFB0Q37347834-9F83C6AC-9139-46FC-B62F-02ADC9F234A2Q37530387-6A0046C9-CD6D-4ED5-9B86-54CDCEF18985Q38120648-8E14BB72-2D04-4487-8286-83B1FFB0D521Q38125769-E8D9D4B0-562A-40F5-95D3-7DB7F3C79A64Q38286283-21FEE953-70CB-47CA-9A1E-B23E3447BB85Q38592069-4B01FCCB-99B2-4559-9E67-F5D95F4A74D2Q38808541-4640A83A-2D2A-4462-B071-31DB021B3160Q39181900-0975D99B-992C-44AB-B534-3DD3359E7077Q39352421-822DF300-D689-41BE-88FA-896933AC51CBQ50553594-5485963C-B76F-4845-B3BF-DEB951BAE619Q59049398-1B360F89-9F84-41CD-9744-441DEC84A36C
P2860
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
@en
type
label
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
@en
prefLabel
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
@en
P2860
P356
P1476
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.
@en
P2093
Chantal Bazenet
P2860
P304
P356
10.2217/BMM.12.48
P577
2012-08-01T00:00:00Z